Antibiotic resistance in staphylococci

International Journal of Antimicrobial Agents

Volumn 16, Issue SUPPL. 1, 2000, Pages 3-10

  Livermore, David M ^a  

^a CENTRAL PUBLIC HEALTH LABORATORY   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBIOTIC AGENT; BETA LACTAM ANTIBIOTIC; DALFOPRISTIN PLUS QUINUPRISTIN; GAMMA GLUTAMYLTRANSFERASE; GLYCOPEPTIDE; PENICILLIN DERIVATIVE; TEICOPLANIN;

ANTIBIOTIC RESISTANCE; ANTIBIOTIC SENSITIVITY; BACTERICIDAL ACTIVITY; COAGULASE NEGATIVE STAPHYLOCOCCUS; CONFERENCE PAPER; EPIDEMIC; INFECTION CONTROL; METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS; NONHUMAN; PRIORITY JOURNAL; STAPHYLOCOCCUS; STAPHYLOCOCCUS AUREUS;

EID: 0034528705     PISSN: 09248579     EISSN: None     Source Type: Journal    
DOI: 10.1016/s0924-8579(00)00299-5     Document Type: Conference Paper

References (58)

1. Staphylococcus aureus (including toxic shock syndrome)
2. Staphylococcus aureus infections
3. Determination of trends in bacteraemia and antibiotic resistance of its pathogens reported in England and Wales between 1990 and 1998
4. A study of carriers of Staphylococcus aureus
5. The changing pattern of infection in neutropenic patients
6. Staphylococcus epidermidis: A significant nosocomial pathogen
7. Further observations on penicillin
8. Infection by penicillin-resistant staphylococci
9. Multi-centre survey of the comparative in vitro activity of piperacillin/tazobactam against bacteria from hospitalised patients in the British Isles
10. A survey of the susceptibility of gram-positive cocci in 25 UK hospitals to linezolid and other antimicrobials
11. Wild-type variants of exopenicillinase from Staphylococcus aureus
12. Cloning and sequence determination of six Staphylococcus aureus β-lactamases and their expression in Escherichia coli and Staphylococcus aureus
13. Antibiotic resistance in Staphylococcus aureus and streptococci
14. Infections caused by a particular phage type of Staphylococcus aureus
15. Epidemic staphylococci
16. β-Lactams: Mode of action and mechanisms of bacterial resistance
17. Celbenin-resistant staphylococci
18. Low-affinity penicillin-binding protein associated with beta-lactam resistance in Staphylococcus aureus
19. Mechanisms of methicillin and vancomycin resistance in Staphylococcus aureus
20. femA, which encodes a factor essential for expression of methicillin resistance, affects glycine content of peptidoglycan in methicillin-resistant and methicillin-susceptible Staphylococcus aureus strains
21. Expression of methicillin resistance in heterogeneous strains of Staphylococcus aureus
22. Transduction of methicillin resistance in Staphylococcus aureus dependent on an unusual specificity of the recipient strain
23. Molecular epidemiology of macrolides-lincosamides-streptogramin B resistance in Staphylococcus aureus and coagulase-negative staphylococci
24. Evidence for a clonal origin of methicillin resistance in Staphylococcus aureus
25. Vancomycin resistance in staphylococci
26. The progressive intercontinental spread of methicillin-resistant Staphylococcus aureus
27. The decline of methicillin resistance among Danish Staphylococcus aureus strains
28. The aacA-aphD gentamicin and kanamycin resistance determinant of Tn-4001 from Staphylococcus aureus: Expression and nucleotide sequence analysis
29. Epidemic methicillin-resistant Staphylococcus aureus
30. Multi-resistant Staphylococcus aureus - A suitable case for inactivity?
31. Revised guidelines for the control of methicillin-resistant Staphylococcus aureus infection in hospital
32. Major outbreak of methicillin-resistant Staphylococcus aureus caused by a new phage type (EMRSA 16)
33. Antimicrobial resistance in gram-positive pathogens isolated in the UK between October 1996 and January 1997
34. Resistance to methicillin and other antibiotics in isolates of Staphylococcus aureus from blood and cerebrospinal fluid, England and Wales, 1989-95
35. The worldwide prevalence of methicillin-resistant Staphylococcus aureus
36. A survey of Staphylococcus aureus for typing and drug-resistance in various areas of Japan during 1992 and 1993
37. Murpirocin-resistant Staphylococcus aureus
38. Prevalence of mupirocin resistance in Staphylococcus aureus
39. Annual changes in isolation of MRSA in our department and chemotherapeutic effect of antibiotics including minocycline against postoperative infections of methicillin-resistance S. aureus
40. Efficacy of combination therapy against MRSA in Ibaraki Prefecture
41. Co-transfer of vancomycin and other resistance genes from Enterococcus faecalis NCTC 12 201 to Staphylococcus aureus
42. High-level resistance of Staphylococcus aureus to vancomycin (VRSA) in Guatemala strains
43. Methicillin-resistant Staphylococcus aureus clinical strain with reduced vancomycin susceptibility
44. Staphylococcus aureus with reduced susceptibility to vancomycin - United States
45. First clinical isolate of vancomycin-intermediate Staphylococcus aureus in a French hospital
46. Dissemination in Japanese hospitals of strains of Staphylococcus aureus heterogeneously resistant to vancomycin
47. Vancomycin resistance among epidemic strains of methicillin-resistant Staphylococcus aureus in England and Wales
48. Twenty months of screening for vancomycin-intermediate Staphylococcus aureus
49. Prevalence of Staphylococcus aureus and coagulase-negative staphylococci with decreased sensitivity to glycopeptides as assessed by determination of MICs
50. Control of methicillin-resistant Staphylococcus aureus in the Netherlands
51. Murpirocin-resistant methicillin-resistant Staphylococcus aureus in Western Australia
52. A point mutation in norA gene is responsible for quinolone resistance in Staphylococcus aureus
53. Quinupristin/dalfopristin: A novel selective-spectrum antibiotic for the treatment of multi-resistant and other gram-positive pathogens
54. New antibiotics for gram-positive infections
55. Activity of linezolid against multi-resistant gram-positive bacteria from diverse hospitals in the United Kingdom
56. Inhibition of protein synthesis by streptogramins and related antibiotics
57. Synercid® (quinupristin/dalfopristin) joins the antimicrobial arsenal